NCT00857857View on ClinicalTrials.gov

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 16, 2009

Primary Completion Date

November 3, 2009

Study Completion Date

November 3, 2009

Conditions
Asthma
Interventions
DRUG

GW870086X

Investigational product

DRUG

FP

Positive control

DRUG

Placebo

Placebo control

Trial Locations (4)

14050

GSK Investigational Site, Berlin

22927

GSK Investigational Site, Großhansdorf

30625

GSK Investigational Site, Hanover

65187

GSK Investigational Site, Wiesbaden

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00857857 - A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics | Biotech Hunter | Biotech Hunter